ALNY - Company ID 0001178670
As of 2026-11-06, ALNYLAM PHARMACEUTICALS, INC. (ALNY) has a market capitalization of $20.99 B, making it the #600 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $20.99 B |
| 2026-11-05 | $20.98 B |
| 2026-11-04 | $21.60 B |
| 2026-11-03 | $21.42 B |
| 2026-11-02 | $21.47 B |
| 2026-11-01 | $21.88 B |
| 2026-10-31 | $21.88 B |
| 2026-10-30 | $22.18 B |
| 2026-10-29 | $23.29 B |
| 2026-10-28 | $30.71 B |
| 2026-10-27 | $30.08 B |
| 2026-10-26 | $30.19 B |
As of 2026-11-06, ALNYLAM PHARMACEUTICALS, INC. (ALNY) has a market capitalization of $20.99 B, making it the #600 most valuable US-listed company.
ALNYLAM PHARMACEUTICALS, INC. is the #600 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $29.71 B |
| 2026-10-24 | $29.71 B |
| 2026-10-23 | $29.71 B |
| 2026-10-22 | $30.14 B |
| 2026-10-21 | $29.85 B |
| 2026-10-20 | $30.60 B |
| 2026-10-19 | $31.14 B |
| 2026-10-18 | $30.75 B |
| 2026-10-17 | $30.75 B |
| 2026-10-16 | $30.93 B |
| 2026-10-15 | $31.04 B |
| 2026-10-14 | $29.77 B |
| 2026-10-13 | $29.68 B |
| 2026-10-12 | $30.21 B |
| 2026-10-11 | $30.86 B |
| 2026-10-10 | $30.86 B |
| 2026-10-09 | $30.86 B |
| 2026-10-08 | $29.73 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.